- Home
- UAMY vs ICCM Comparison
UAMY vs ICCM Comparison
Compare UAMY & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UAMY | ICCM |
|---|---|---|
| Founded | 1968 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 955.8M | 8.3M |
| IPO Year | 1997 | 2013 |
Fundamental Metrics
Financial Performance| Metric | UAMY | ICCM |
|---|---|---|
| Price | $4.17 | $1.65 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $10.44 | ★ $22.67 |
| AVG Volume (30 Days) | ★ 4.3M | 90.1K |
| Earning Date | 11-11-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $39,257,708.00 | N/A |
| Revenue This Year | $65.44 | $34.08 |
| Revenue Next Year | $210.77 | $94.31 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 162.80 | N/A |
| 52 Week Low | $4.16 | $0.13 |
| 52 Week High | $19.71 | $9.54 |
Technical Indicators
Market Signals| Indicator | UAMY | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 34.54 | 24.80 |
| Support Level | N/A | $0.22 |
| Resistance Level | $5.70 | $2.50 |
| Average True Range (ATR) | 0.18 | 0.15 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 0.00 | 12.71 |
Price Performance
Historical ComparisonAbout UAMY United States Antimony Corporation
United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has two operating segments: antimony and zeolite. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the Domestic, Canada, and Mexico, of which the vast majority of its revenue comes from the Domestic.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.